FDA's US-First Strategy: Device Center Sets Three-Year Goals

A new three-year plan to implement strategic priorities at US FDA's device center aims to make several broad improvements to the medtech ecosystem. Among them is improving staff incentives at the agency, creating more partnerships with industry and other stakeholders, and improving the center's processes to make it easier for novel medical devices to enter the US market.

Empty asphalt road and New year 2018, 2019, 2020 concept. Driving on an empty road in the mountains to upcoming 2018, 2019, 2020 and leaving behind old years. Concept for success and passing time.

US FDA's device center will focus on improving staff engagement, streamlining its core processes and boosting collaborations with stakeholder communities over the next three years. That's the message from its strategic priorities document published the agency's device center on Jan. 17. The overall aim: by 2020, to have a majority of manufacturers of novel technologies intend to bring their devices to the US first or in parallel with other major global markets.

Medtech Insight sat down with Center for Devices and Radiological Health (CDRH) Director Jeff Shuren to talk about how the...

Welcome to Medtech Insight

Create an account to read this article

More from Regulation

As Medtech Tariffs Loom, AdvaMed Responds With Its Own Plan Emphasizing ‘Reciprocal’ Free Trade

 

The US Department of Commerce’s investigation into the national security impact of importing various medical equipment could lead to tariffs on many products. Device industry responds by emphasizing the robustness of domestic production, but also the rigidity of supply and reimbursement agreements.

Persistence Pays Off: New International Clinical Evaluation Standard Is Finally On Horizon

 

Clinical evaluation and standards expert Danielle Giroud celebrates progress on the document and looks at what it means internationally and for the EU.

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By 

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

More from Policy & Regulation

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By 

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

MedTech Innovator Winner Armor Medical Hopes To Reduce 90% Of Preventable Maternal Deaths

 
• By 

Armor Medical’s wrist-worn wearable detected postpartum hemorrhage five times earlier than standard care in earlier studies. After surviving near-fatal hemorrhage herself, co-founder/CEO Kelsey Mayo aims to bring the device to market in 2028.